Experiences with
Benlysta68 public posts
Share you experiences of belimumab (Benlysta)
Hi everyone,
You may be aware that LUPUS UK is a stakeholder in the current NICE appraisal process for belimumab (Benlysta), which we hope will result in more people with lupus having access to the treatment through the NHS.
Lupus patients who are currently undergoing biologic treatment (Benlysta/Rituximab) needed for paid research study
Global Patients, a market research company specialising in the healthcare sector, are looking for two people with systemic lupus erythematosus who are currently undergoing biologic treatment (Benlysta (belimumab)/Rituximab) to take part in a research study.
Should You Get the COVID-19 Vaccine During a Disease Flare-Up?
Cyclophosphamide (Cytoxan) (oral)
TNF biologics (ex: Cimzia, Enbrel, Humira, Remicade, Simponi and Simponi Aria)
IL-6 biologics (ex: Actemra, Kevzara)
IL-1 biologics (ex: Kineret, Ilaris)
IL-17 biologics (ex: Cosentyx, Taltz)
IL-23 biologics (ex: Skyrizi, Tremfya)
IL-12/23 biologics (ex: Stelara)
Belimumab (Benlysta
Want to take advantage of all our features? Just log in!
or
7 Questions to Ask Your Rheumatologist If You’re Nervous About Getting the COVID-19 Vaccine
Cyclophosphamide (Cytoxan) (oral)
TNF biologics (ex: Cimzia, Enbrel, Humira, Remicade, Simponi and Simponi Aria)
IL-6 biologics (ex: Actemra, Kevzara)
IL-1 biologics (ex: Kineret, Ilaris)
IL-17 biologics (ex: Cosentyx, Taltz)
IL-23 biologics (ex: Skyrizi, Tremfya)
IL-12/23 biologics (ex: Stelara)
Belimumab (Benlysta
Getting a COVID-19 Vaccine with Autoimmune or Inflammatory Rheumatic Disease: New Guidance from the American College of Rheumatology
Cyclophosphamide (Cytoxan) (oral)
TNF biologics (ex: Cimzia, Enbrel, Humira, Remicade, Simponi and Simponi Aria)
IL-6 biologics (ex: Actemra, Kevzara)
IL-1 biologics (ex: Kineret, Ilaris)
IL-17 biologics (ex: Cosentyx, Taltz)
IL-23 biologics (ex: Skyrizi, Tremfya)
IL-12/23 biologics (ex: Stelara)
Belimumab (Benlysta
NICE appraisal of belimumab (Benlysta) - please complete our anonymous online survey
The National Institute for Health and Care Excellence (NICE) are doing an appraisal of belimumab (Benlysta) to produce new guidance for its use in the treatment of adults with SLE in England.
LUPUS UK is a registered consultee (stakeholder) and will be submitting evidence.
Benlysta Treatment Lowers Disease Activity for SLE Patients, Real-world Data Shows
SOURCE: https://lupusnewstoday.com/benlysta-lowers-disease-activity-organ-damage-sle-patients-real-world-data?
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
Read Announcement from GSK
https://www.lupusresearch.org/new-phase-3-study-shows-positive-results-for-benlysta-in-lupus-nephritis/
LUpus Patients Understanding & Support (LUPUS): https://www.lupus-support.org/topic/3163-new-phase-3-study-shows-positive-results-for-benlysta%C2%AE-in-lupus-nephritis
LRA Shares Excitement For What’s Ahead in Lupus Nephritis
Food and Drug Administration (FDA) for approval of their drugs to treat lupus nephritis based on positive Phase III trial results with Benlysta® (belimumab) and voclosporin respectively.
Two new Phase III trials are starting up to test potential treatments – Gazyva® (obinutuzumab) and secukinumab.
LRA Celebrates Major Research Breakthroughs in 2019
First and Only Lupus Treatment Approved for Use in Children — Benlysta (belimumab) was approved by the U.S. FDA to treat children with lupus who are five years old or above.
LRA Celebrates Major Research Breakthroughs in 2019
First and Only Lupus Treatment Approved for Use in Children — Benlysta (belimumab) was approved by the U.S. FDA to treat children with lupus who are five years old or above.
Benlysta Maintenance Does Not Change Kidney Function of Lupus Nephritis Patients, Phase 2 Trial Shows
Source: lupusnewstoday.com/2018/11/21/no-change-kidney-function-benlysta-maintenance-lupus-nephritis-patients-phase-2-trial/
Jose Marques Lopes, PhDNovember 21, 2018
Benlysta Maintenance Does Not Change Kidney Function of Lupus Nephritis Patients, Phase 2 Trial Shows
Using Benlysta (belimumab) as a maintenance